Aaron S. Kesselheim

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Aaron S. Kesselheim
Dec 24, 2024, 18:11 | Blog
Bishal Gyawali: Are U.S. patients paying twice for cancer drugs?
Bishal Gyawali, Associate Professor at Queen’s University, shared on X: “Are U.S. patients paying twice…
Dec 21, 2024, 08:29 | Science
Bishal Gyawali: The case of cancer drug Xtandi
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, Canada, posted on LinkedIn about recent paper…
Oct 13, 2024, 14:48 | Blog
Exploring Fines as a Solution to Delays in FDA Drugs Approval Trails
Ash Paul, Public Health Doctor, shared a recent article by C. Joseph Ross Daval, Program…
Aug 27, 2024, 22:10 | Insight
Erman Akkus: Genome targeted cancer therapies in NCCN guidelines according to the ESMO MCBS and ESCAT
Erman Akkus, Medical Oncology Fellow at Ankara University Faculty of Medicine, shared a post on…
Jul 27, 2024, 14:57 | Insight
Edward Cliff: The development and clinical trial design of T-cell lymphoma drugs pralatrexate and belinostat
Edward Cliff, Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, shared a…
Jul 10, 2024, 09:09 | Blog
William Feldman: Looking at payer-negotiated prices on oncology drugs at pediatric 340B hospitals
William Feldman, Assistant Professor at Harvard Medical School and Ethics Co-Chair at Brigham and Women's…
May 7, 2024, 10:54 | Career
Edward Cliff is starting a new position as Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital!
Edward Cliff, Haematology Registrar at Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, shared…
All: 7 Posts: 1 - 100
Special Coverage